GB929401A
(en)
|
1958-12-22 |
1963-06-19 |
Upjohn Co |
Encapsulated emulsions and processes for their preparation
|
GB929405A
(en)
|
1958-12-22 |
1963-06-19 |
Upjohn Co |
Processes for the encapsulation of particles
|
GB969808A
(en)
|
1962-06-08 |
1964-09-16 |
Boots Pure Drug Co Ltd |
Anthelmintic compositions and compounds
|
IT1148784B
(it)
|
1980-04-09 |
1986-12-03 |
Eurand Spa |
Procedimento per la preparazione di microcapsule in un veicolo liquido
|
US4946929A
(en)
|
1983-03-22 |
1990-08-07 |
Massachusetts Institute Of Technology |
Bioerodible articles useful as implants and prostheses having predictable degradation rates
|
US4794000A
(en)
|
1987-01-08 |
1988-12-27 |
Synthetic Blood Corporation |
Coacervate-based oral delivery system for medically useful compositions
|
US4638045A
(en)
|
1985-02-19 |
1987-01-20 |
Massachusetts Institute Of Technology |
Non-peptide polyamino acid bioerodible polymers
|
US4806621A
(en)
|
1986-01-21 |
1989-02-21 |
Massachusetts Institute Of Technology |
Biocompatible, bioerodible, hydrophobic, implantable polyimino carbonate article
|
US5736372A
(en)
|
1986-11-20 |
1998-04-07 |
Massachusetts Institute Of Technology |
Biodegradable synthetic polymeric fibrous matrix containing chondrocyte for in vivo production of a cartilaginous structure
|
US5759830A
(en)
|
1986-11-20 |
1998-06-02 |
Massachusetts Institute Of Technology |
Three-dimensional fibrous scaffold containing attached cells for producing vascularized tissue in vivo
|
CA1340581C
(en)
|
1986-11-20 |
1999-06-08 |
Joseph P. Vacanti |
Chimeric neomorphogenesis of organs by controlled cellular implantation using artificial matrices
|
US5019379A
(en)
|
1987-07-31 |
1991-05-28 |
Massachusetts Institute Of Technology |
Unsaturated polyanhydrides
|
US5110927A
(en)
|
1987-12-31 |
1992-05-05 |
The United States Of America As Represented By The Department Of Health And Human Services |
Prazosin analog with increased selectivity and duration of action
|
JP2528706B2
(ja)
|
1988-05-30 |
1996-08-28 |
ゼリア新薬工業株式会社 |
ジヒドロピリジン化合物の製剤組成物
|
GB8819110D0
(en)
|
1988-08-11 |
1988-09-14 |
Norsk Hydro As |
Antihypertensive drug & method for production
|
US5010167A
(en)
|
1989-03-31 |
1991-04-23 |
Massachusetts Institute Of Technology |
Poly(amide-and imide-co-anhydride) for biological application
|
US5019400A
(en)
|
1989-05-01 |
1991-05-28 |
Enzytech, Inc. |
Very low temperature casting of controlled release microspheres
|
US5013557A
(en)
|
1989-10-03 |
1991-05-07 |
Warner-Lambert Company |
Taste masking compositions comprising spray dried microcapsules containing sucralfate and methods for preparing same
|
ES2111065T5
(es)
|
1991-04-16 |
2005-06-16 |
Nippon Shinyaku Company, Limited |
Procedimiento para producir una dispersion solida.
|
TW209174B
(ja)
|
1991-04-19 |
1993-07-11 |
Takeda Pharm Industry Co Ltd |
|
GB9206757D0
(en)
|
1992-03-27 |
1992-05-13 |
Ferring Bv |
Novel peptide receptor ligands
|
AU4198793A
(en)
|
1992-07-24 |
1994-01-27 |
Takeda Chemical Industries Ltd. |
Microparticle preparation and production thereof
|
US5399665A
(en)
|
1992-11-05 |
1995-03-21 |
Massachusetts Institute Of Technology |
Biodegradable polymers for cell transplantation
|
US5512600A
(en)
|
1993-01-15 |
1996-04-30 |
Massachusetts Institute Of Technology |
Preparation of bonded fiber structures for cell implantation
|
US5514378A
(en)
|
1993-02-01 |
1996-05-07 |
Massachusetts Institute Of Technology |
Biocompatible polymer membranes and methods of preparation of three dimensional membrane structures
|
US5543158A
(en)
|
1993-07-23 |
1996-08-06 |
Massachusetts Institute Of Technology |
Biodegradable injectable nanoparticles
|
US5565215A
(en)
|
1993-07-23 |
1996-10-15 |
Massachusettes Institute Of Technology |
Biodegradable injectable particles for imaging
|
GB9322014D0
(en)
|
1993-10-26 |
1993-12-15 |
Co Ordinated Drug Dev |
Improvements in and relating to carrier particles for use in dry powder inhalers
|
SE9401109D0
(sv)
|
1994-03-31 |
1994-03-31 |
Leiras Oy |
Opthalmic composition II
|
SE9401108D0
(sv)
|
1994-03-31 |
1994-03-31 |
Leiras Oy |
Ophthalmic composition I
|
US6074642A
(en)
|
1994-05-02 |
2000-06-13 |
Alexion Pharmaceuticals, Inc. |
Use of antibodies specific to human complement component C5 for the treatment of glomerulonephritis
|
GB9412273D0
(en)
|
1994-06-18 |
1994-08-10 |
Univ Nottingham |
Administration means
|
IT1271679B
(it)
|
1994-07-18 |
1997-06-04 |
Mediolanum Farmaceutici Srl |
Derivati del fenilcarbammato atti all'impiego come anticolinesterasici
|
US6007845A
(en)
|
1994-07-22 |
1999-12-28 |
Massachusetts Institute Of Technology |
Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers
|
US5716404A
(en)
|
1994-12-16 |
1998-02-10 |
Massachusetts Institute Of Technology |
Breast tissue engineering
|
DK0797987T3
(da)
|
1994-12-19 |
2004-02-16 |
Daiichi Seiyaku Co |
Granulært præparat med langvarig frigivelse og fremgangsmåde til fremstilling deraf
|
GB9501841D0
(en)
|
1995-01-31 |
1995-03-22 |
Co Ordinated Drug Dev |
Improvements in and relating to carrier particles for use in dry powder inhalers
|
US6413539B1
(en)
|
1996-10-31 |
2002-07-02 |
Poly-Med, Inc. |
Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof
|
US6123727A
(en)
|
1995-05-01 |
2000-09-26 |
Massachusetts Institute Of Technology |
Tissue engineered tendons and ligaments
|
GB9515182D0
(en)
|
1995-07-24 |
1995-09-20 |
Co Ordinated Drug Dev |
Improvements in and relating to powders for use in dry powder inhalers
|
JP3938938B2
(ja)
|
1995-07-26 |
2007-06-27 |
協和醗酵工業株式会社 |
キサンチン誘導体の固体分散体または固体分散体製剤
|
WO1997011698A1
(en)
|
1995-09-29 |
1997-04-03 |
Merck & Co., Inc. |
ALPHA 1b ADRENERGIC RECEPTOR ANTAGONISTS
|
US5747490A
(en)
|
1995-09-29 |
1998-05-05 |
Merck & Co., Inc. |
Alpha 1b adrenergic receptor antagonists
|
US6095148A
(en)
|
1995-11-03 |
2000-08-01 |
Children's Medical Center Corporation |
Neuronal stimulation using electrically conducting polymers
|
AU7626496A
(en)
|
1995-12-01 |
1997-06-27 |
Ciba-Geigy Ag |
Heteroaryl compounds
|
NZ325248A
(en)
|
1995-12-23 |
1999-09-29 |
Pfizer Res & Dev |
Quinoline and quinazoline compounds useful in therapy
|
US5902599A
(en)
|
1996-02-20 |
1999-05-11 |
Massachusetts Institute Of Technology |
Biodegradable polymer networks for use in orthopedic and dental applications
|
US6497903B1
(en)
|
1996-07-01 |
2002-12-24 |
Wilhelmus Everhardus Hennink |
Hydrolysable hydrogels for controlled release
|
EP0842657A1
(en)
|
1996-11-19 |
1998-05-20 |
OctoPlus B.V. |
Microspheres for controlled release and processes to prepare these microspheres
|
US6395302B1
(en)
|
1996-11-19 |
2002-05-28 |
Octoplus B.V. |
Method for the preparation of microspheres which contain colloidal systems
|
AU7808198A
(en)
|
1997-06-03 |
1998-12-21 |
Biocryst Pharmaceuticals, Inc. |
Novel compounds useful in the complement, coagulat and kallikrein pathways and method for their preparation
|
JPH1123485A
(ja)
|
1997-07-07 |
1999-01-29 |
Tani Denki Kogyo Kk |
基板検査方法及び基板検査装置
|
US5837752A
(en)
|
1997-07-17 |
1998-11-17 |
Massachusetts Institute Of Technology |
Semi-interpenetrating polymer networks
|
ATE364374T1
(de)
|
1997-08-11 |
2007-07-15 |
Pfizer Prod Inc |
Feste pharmazeutische dispersionen mit erhöhter bioverfügbarkeit
|
US6506577B1
(en)
|
1998-03-19 |
2003-01-14 |
The Regents Of The University Of California |
Synthesis and crosslinking of catechol containing copolypeptides
|
US6632922B1
(en)
|
1998-03-19 |
2003-10-14 |
The Regents Of The University Of California |
Methods and compositions for controlled polypeptide synthesis
|
US6686446B2
(en)
|
1998-03-19 |
2004-02-03 |
The Regents Of The University Of California |
Methods and compositions for controlled polypeptide synthesis
|
AU754716B2
(en)
|
1998-03-26 |
2002-11-21 |
Japan Tobacco Inc. |
Amide derivatives and nociceptin antagonists
|
WO2000021559A2
(en)
|
1998-10-09 |
2000-04-20 |
Musc Foundation For Research Development |
Blocking factor b to treat complement-mediated immune disease
|
GB9827145D0
(en)
|
1998-12-09 |
1999-02-03 |
Co Ordinated Drug Dev |
Improvements in or relating to powders
|
JP2000281660A
(ja)
|
1999-03-29 |
2000-10-10 |
Sumitomo Pharmaceut Co Ltd |
キナゾリン誘導体
|
US6287588B1
(en)
|
1999-04-29 |
2001-09-11 |
Macromed, Inc. |
Agent delivering system comprised of microparticle and biodegradable gel with an improved releasing profile and methods of use thereof
|
IT1312310B1
(it)
|
1999-05-07 |
2002-04-15 |
Recordati Ind Chimica E Farma |
Uso di antagonisti selettivi del recettore adrenergico a 1b per ilmiglioramento della disfunzione sessuale
|
GB9927011D0
(en)
|
1999-11-16 |
2000-01-12 |
Advanced Phytonics Ltd |
Method for the production of particles
|
DE60020732T2
(de)
|
1999-12-20 |
2006-05-11 |
Kerkhof, Nicholas J., Rio Vista |
Verfahren zur herstellung von nanometer partikeln durch fliessbett- sprühtrocknung
|
US20020015731A1
(en)
|
1999-12-23 |
2002-02-07 |
Appel Leah E. |
Hydrogel-Driven Drug Dosage Form
|
EP1712222A3
(en)
|
1999-12-23 |
2012-06-20 |
Pfizer Products Inc. |
Pharmaceutical compositions providing enhanced drug concentrations
|
CN1406140A
(zh)
|
2000-02-28 |
2003-03-26 |
吉倪塞思公司 |
纳米胶囊包封系统与方法
|
WO2001068615A1
(en)
|
2000-03-13 |
2001-09-20 |
Chemrx Advanced Technologies, Inc. |
Quinazoline synthesis
|
EP1279406A4
(en)
|
2000-04-03 |
2007-10-24 |
Santen Pharmaceutical Co Ltd |
TRANSPORTERS AND DRUG DISPENSING SYSTEMS USING THESE
|
GB0009468D0
(en)
|
2000-04-17 |
2000-06-07 |
Vectura Ltd |
Improvements in or relating to formulations for use in inhaler devices
|
GB0009469D0
(en)
|
2000-04-17 |
2000-06-07 |
Vectura Ltd |
Improvements in or relating to formalities for use in inhaler devices
|
US6589549B2
(en)
|
2000-04-27 |
2003-07-08 |
Macromed, Incorporated |
Bioactive agent delivering system comprised of microparticles within a biodegradable to improve release profiles
|
US6495164B1
(en)
|
2000-05-25 |
2002-12-17 |
Alkermes Controlled Therapeutics, Inc. I |
Preparation of injectable suspensions having improved injectability
|
PT1913939T
(pt)
|
2000-06-27 |
2017-07-19 |
Vectura Ltd |
Formulações para utilização em dispositivos inalatórios
|
GB2364919A
(en)
|
2000-07-21 |
2002-02-13 |
Cambridge Consultants |
Inhalers
|
GB0021024D0
(en)
|
2000-08-29 |
2000-10-11 |
Glaxo Group Ltd |
Inhalation device
|
JP2004534721A
(ja)
|
2000-10-31 |
2004-11-18 |
ピーアール ファーマシューティカルズ,インク. |
生理活性分子の向上した送達のための方法及び組成物
|
PT1337239E
(pt)
|
2000-11-30 |
2010-01-26 |
Vectura Ltd |
Partículas servindo à preparação de uma composição farmacêutica
|
US6818732B2
(en)
|
2001-08-30 |
2004-11-16 |
The Regents Of The University Of California |
Transition metal initiators for controlled poly (beta-peptide) synthesis from beta-lactam monomers
|
GB0122318D0
(en)
|
2001-09-14 |
2001-11-07 |
Novartis Ag |
Organic compounds
|
EP1469829B1
(en)
|
2002-02-01 |
2016-01-27 |
Bend Research, Inc |
Immediate release dosage forms containing solid drug dispersions
|
EP1567487A4
(en)
|
2002-11-15 |
2005-11-16 |
Bristol Myers Squibb Co |
OPEN-CHAINED, PROLYL-FROSTED MODULATORS OF ANDROGEN RECEPTOR FUNCTION
|
US20050009910A1
(en)
|
2003-07-10 |
2005-01-13 |
Allergan, Inc. |
Delivery of an active drug to the posterior part of the eye via subconjunctival or periocular delivery of a prodrug
|
NZ545484A
(en)
|
2003-09-15 |
2009-09-25 |
Vectura Ltd |
Pharmaceutical compositions for treating premature ejaculation by pulmonary inhalation
|
US7585517B2
(en)
|
2003-09-18 |
2009-09-08 |
Macusight, Inc. |
Transscleral delivery
|
CN1997691B
(zh)
|
2003-09-23 |
2011-07-20 |
北卡罗来纳大学查珀尔希尔分校 |
光固化的全氟聚醚用作微流体器件中的新材料
|
SE0302665D0
(sv)
|
2003-10-07 |
2003-10-07 |
Astrazeneca Ab |
Novel Process
|
WO2005044186A2
(en)
|
2003-10-28 |
2005-05-19 |
Glaxo Group Limited |
Inhalable pharmaceutical formulations employing desiccating agents and methods of administering the same
|
MXPA06006738A
(es)
|
2003-12-19 |
2006-08-31 |
Univ North Carolina |
Metodos para fabricar micro- y nano-estructuras aisladas utilizando litografia suave o de impresion.
|
US8957034B2
(en)
|
2004-01-28 |
2015-02-17 |
Johns Hopkins University |
Drugs and gene carrier particles that rapidly move through mucous barriers
|
US8158728B2
(en)
|
2004-02-13 |
2012-04-17 |
The University Of North Carolina At Chapel Hill |
Methods and materials for fabricating microfluidic devices
|
GB0407627D0
(en)
|
2004-04-02 |
2004-05-05 |
Vectura Ltd |
Corkscrew pump
|
US7745436B2
(en)
|
2004-04-13 |
2010-06-29 |
Synta Pharmaceuticals Corporation |
Disalt inhibitors of IL-12 production
|
ES2246694B1
(es)
|
2004-04-29 |
2007-05-01 |
Instituto Cientifico Y Tecnologico De Navarra, S.A. |
Nanoparticulas pegiladas.
|
BRPI0510485A
(pt)
|
2004-04-30 |
2007-11-13 |
Allergan Inc |
implantes inibidores de tirosina cinase intravìtreos biodegradáveis
|
US20050244469A1
(en)
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Extended therapeutic effect ocular implant treatments
|
US7771742B2
(en)
|
2004-04-30 |
2010-08-10 |
Allergan, Inc. |
Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
|
JP2007269629A
(ja)
|
2004-06-21 |
2007-10-18 |
Astellas Pharma Inc |
キナゾリン誘導体
|
PL370285A1
(pl)
|
2004-09-23 |
2006-04-03 |
Glaxosmithkline Pharmaceuticals Spółka Akcyjna |
Inhalator proszkowy
|
EP1855652B1
(en)
|
2005-01-28 |
2015-12-02 |
Bend Research, Inc |
Drying of drug-containing particles
|
EP2548894A1
(en)
|
2005-02-03 |
2013-01-23 |
Bend Research, Inc. |
Pharmaceutical compositions with enhanced performance
|
US8663639B2
(en)
|
2005-02-09 |
2014-03-04 |
Santen Pharmaceutical Co., Ltd. |
Formulations for treating ocular diseases and conditions
|
EP1848431B1
(en)
|
2005-02-09 |
2016-02-03 |
Santen Pharmaceutical Co., Ltd. |
Liquid formulations for treatment of diseases or conditions
|
MX2007016039A
(es)
|
2005-06-17 |
2008-10-27 |
Univ North Carolina |
Metodos, sistemas y materiales de fabricacion de nanoparticulas.
|
US20070071756A1
(en)
|
2005-09-26 |
2007-03-29 |
Peyman Gholam A |
Delivery of an agent to ameliorate inflammation
|
US20070178133A1
(en)
|
2005-11-09 |
2007-08-02 |
Liquidia Technologies, Inc. |
Medical device, materials, and methods
|
CN101360738A
(zh)
|
2005-12-21 |
2009-02-04 |
佩因赛普托药物公司 |
调节门控离子通道的组合物和方法
|
WO2007076358A1
(en)
|
2005-12-23 |
2007-07-05 |
Alcon, Inc. |
PHARMACEUTICAL FORMULATION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE
|
WO2007081876A2
(en)
|
2006-01-04 |
2007-07-19 |
Liquidia Technologies, Inc. |
Nanostructured surfaces for biomedical/biomaterial applications and processes thereof
|
CA2636716C
(en)
|
2006-01-13 |
2014-12-23 |
Surmodics, Inc. |
Microparticle containing matrices for drug delivery
|
PL2001466T3
(pl)
|
2006-03-23 |
2016-06-30 |
Santen Pharmaceutical Co Ltd |
Rapamycyna w małej dawce do leczenia chorób związanych z przepuszczalnością naczyń
|
US20080166411A1
(en)
|
2006-04-10 |
2008-07-10 |
Pfizer Inc |
Injectable Depot Formulations And Methods For Providing Sustained Release Of Poorly Soluble Drugs Comprising Nanoparticles
|
WO2007133808A2
(en)
|
2006-05-15 |
2007-11-22 |
Liquidia Technologies, Inc. |
Nano-particles for cosmetic applications
|
WO2008003702A2
(en)
|
2006-07-03 |
2008-01-10 |
Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patientenzorg |
Fused bicyclic compounds interacting with the histamine h4 receptor
|
US8465775B2
(en)
|
2006-07-27 |
2013-06-18 |
The University Of North Carolina At Chapel Hill |
Nanoparticle fabrication methods, systems, and materials for fabricating artificial red blood cells
|
GB0617480D0
(en)
|
2006-09-06 |
2006-10-18 |
Univ Sheffield |
Novel nanoparticles
|
US20100215580A1
(en)
|
2006-09-08 |
2010-08-26 |
The Johns Hopkins University |
Compositions and methods for enhancing transport through mucus
|
US9022970B2
(en)
|
2006-10-16 |
2015-05-05 |
Alcon Research, Ltd. |
Ophthalmic injection device including dosage control device
|
KR20090082447A
(ko)
|
2006-11-09 |
2009-07-30 |
알콘 리서치, 리미티드 |
약물 전달용 수불용성 폴리머 매트릭스
|
WO2008100304A2
(en)
|
2006-11-15 |
2008-08-21 |
The University Of North Carolina At Chapel Hill |
Polymer particle composite having high fidelity order, size, and shape particles
|
KR20090122465A
(ko)
|
2007-03-01 |
2009-11-30 |
어드벤스드 비젼 테라피스, 인코포레이티드 |
염증성 질환의 치료
|
EP2620157A3
(en)
|
2007-10-12 |
2013-10-16 |
Massachusetts Institute of Technology |
Vaccine nanotechnology
|
US20090203709A1
(en)
|
2008-02-07 |
2009-08-13 |
Abbott Laboratories |
Pharmaceutical Dosage Form For Oral Administration Of Tyrosine Kinase Inhibitor
|
WO2009145842A2
(en)
|
2008-04-04 |
2009-12-03 |
Forsight Labs, Llc |
Therapeutic device for pain management and vision
|
WO2009132206A1
(en)
|
2008-04-25 |
2009-10-29 |
Liquidia Technologies, Inc. |
Compositions and methods for intracellular delivery and release of cargo
|
WO2009132265A2
(en)
|
2008-04-25 |
2009-10-29 |
The University Of North Carolina At Chapel Hill |
Degradable compounds and methods of use thereof, particularly with particle replication in non-wetting templates
|
EP2133334A1
(en)
|
2008-06-09 |
2009-12-16 |
DAC S.r.l. |
Heterocyclic derivatives as HDAC inhibitors
|
WO2010009087A1
(en)
|
2008-07-15 |
2010-01-21 |
Eyegate Pharmaceuticals, Inc. |
Iontophoretic delivery of a controlled-release formulation in the eye
|
US9095670B2
(en)
|
2008-10-08 |
2015-08-04 |
Astrazeneca Ab |
Inhalation device and method of dispensing medicament
|
WO2010065748A2
(en)
|
2008-12-05 |
2010-06-10 |
Liquidia Technologies, Inc. |
Method for producing patterned materials
|
CN102271676B
(zh)
|
2008-12-30 |
2014-07-23 |
希尔氏宠物营养品公司 |
硫辛酸在治疗或预防陪伴动物的退行性关节病症、骨关节炎、软骨损伤,以及相关障碍中的应用
|
US8623395B2
(en)
|
2010-01-29 |
2014-01-07 |
Forsight Vision4, Inc. |
Implantable therapeutic device
|
CN102365109B
(zh)
|
2009-01-29 |
2015-06-03 |
弗赛特影像4股份有限公司 |
后段给药
|
WO2010091187A2
(en)
|
2009-02-04 |
2010-08-12 |
The Brigham And Women's Hospital, Inc. |
Polymeric nanoparticles with enhanced drug-loading and methods of use thereof
|
WO2010093727A1
(en)
*
|
2009-02-10 |
2010-08-19 |
Janssen Pharmaceutica Nv |
Quinazolinones as prolyl hydroxylase inhibitors
|
JP5969212B2
(ja)
|
2009-02-10 |
2016-08-17 |
シヴィダ・ユーエス・インコーポレイテッドPsivida Us,Inc. |
眼用トロカール組立体
|
CA2790324C
(en)
|
2009-02-26 |
2022-06-14 |
Joseph Desimone |
Interventional drug delivery system and associated methods
|
US10952965B2
(en)
|
2009-05-15 |
2021-03-23 |
Baxter International Inc. |
Compositions and methods for drug delivery
|
WO2010141729A1
(en)
|
2009-06-03 |
2010-12-09 |
Forsight Labs, Llc |
Anterior segment drug delivery
|
JP5656996B2
(ja)
|
2009-07-13 |
2015-01-21 |
ザ ユニバーシティ オブ ノース キャロライナ アット チャペル ヒル |
工学的に作製されたエアロゾル粒子、およびそれに関連した方法
|
TWI492769B
(zh)
|
2009-09-23 |
2015-07-21 |
Alcon Res Ltd |
可注射的水性眼用組成物及其使用之方法
|
WO2011050365A1
(en)
|
2009-10-23 |
2011-04-28 |
Forsight Labs, Llc |
Conformable therapeutic shield for vision and pain
|
WO2011050327A1
(en)
|
2009-10-23 |
2011-04-28 |
Forsight Labs Llc |
Corneal denervation for treatment of ocular pain
|
TWI478730B
(zh)
|
2009-12-03 |
2015-04-01 |
Alcon Res Ltd |
眼科乳劑
|
WO2013022801A1
(en)
|
2011-08-05 |
2013-02-14 |
Forsight Vision4, Inc. |
Small molecule delivery with implantable therapeutic device
|
US8889193B2
(en)
|
2010-02-25 |
2014-11-18 |
The Johns Hopkins University |
Sustained delivery of therapeutic agents to an eye compartment
|
WO2011109384A2
(en)
|
2010-03-02 |
2011-09-09 |
Allergan, Inc. |
Biodegradable polymers for lowering intraocular pressure
|
EP2566447B1
(en)
|
2010-05-05 |
2020-07-15 |
Alcon Inc. |
Stabilized ophthalmic galactomannan formulations
|
WO2011153349A1
(en)
|
2010-06-02 |
2011-12-08 |
Alcon Research, Ltd. |
Ophthalmic compositions comprising pbo-peo-pbo block copolymers
|
JP6063382B2
(ja)
|
2010-08-05 |
2017-01-18 |
フォーサイト・ビジョン フォー・インコーポレーテッド |
治療薬を眼の埋め込み体へと注入するためのシステム
|
WO2012019139A1
(en)
|
2010-08-05 |
2012-02-09 |
Forsight Vision4, Inc. |
Combined drug delivery methods and apparatus
|
HUE057267T2
(hu)
|
2010-08-05 |
2022-05-28 |
Forsight Vision4 Inc |
Berendezés szem kezelésére
|
AU2011285637B2
(en)
|
2010-08-05 |
2014-10-30 |
Forsight Vision4, Inc. |
Subconjunctival implant for posterior segment drug delivery
|
EP2611529B1
(en)
|
2010-09-03 |
2019-01-23 |
Bend Research, Inc. |
Spray-drying method
|
WO2012039979A2
(en)
|
2010-09-10 |
2012-03-29 |
The Johns Hopkins University |
Rapid diffusion of large polymeric nanoparticles in the mammalian brain
|
AU2011323250B2
(en)
|
2010-11-05 |
2015-11-19 |
The Johns Hopkins University |
Compositions and methods relating to reduced mucoadhesion
|
US20140033800A1
(en)
|
2010-11-11 |
2014-02-06 |
Forsight Vision4, Inc. |
Methods and apparatus to determine diffusion properties of porous structures for drug delivery
|
TW201304822A
(zh)
|
2010-11-15 |
2013-02-01 |
Vectura Ltd |
組成物及用途
|
AU2011329656B2
(en)
|
2010-11-19 |
2017-01-05 |
Forsight Vision4, Inc. |
Therapeutic agent formulations for implanted devices
|
MX347391B
(es)
|
2011-01-04 |
2017-04-25 |
Novartis Ag |
Compuestos de indol o análogos de los mismos útiles para el tratamiento de degeneración macular relacionada con la edad (amd).
|
US9327037B2
(en)
|
2011-02-08 |
2016-05-03 |
The Johns Hopkins University |
Mucus penetrating gene carriers
|
WO2012145801A1
(en)
|
2011-04-29 |
2012-11-01 |
Jagat Rakesh Kanwar |
Nanoparticle
|
CN103561765B
(zh)
|
2011-05-05 |
2015-06-17 |
沃尔斯塔特免疫疗法公司 |
补体因子b类似物及其用途
|
US9084727B2
(en)
|
2011-05-10 |
2015-07-21 |
Bend Research, Inc. |
Methods and compositions for maintaining active agents in intra-articular spaces
|
US8691750B2
(en)
|
2011-05-17 |
2014-04-08 |
Axolabs Gmbh |
Lipids and compositions for intracellular delivery of biologically active compounds
|
CN103703490B
(zh)
|
2011-06-29 |
2016-03-30 |
日本电气方案创新株式会社 |
用于产生三维特征数据的设备以及用于产生三维特征数据的方法
|
CA2782956C
(en)
|
2011-06-29 |
2019-08-13 |
Rehrig Pacific Company |
Crate with retractable wall
|
GB201115874D0
(en)
|
2011-09-14 |
2011-10-26 |
Astrazeneca Ab |
Inhaler
|
KR102071083B1
(ko)
|
2011-09-14 |
2020-01-29 |
포사이트 비젼5, 인크. |
안내 삽입물 장치 및 방법
|
PT2755600T
(pt)
|
2011-09-16 |
2021-04-19 |
Forsight Vision4 Inc |
Aparelhos de troca de fluidos
|
EP2785326A2
(en)
|
2011-11-29 |
2014-10-08 |
The University of North Carolina at Chapel Hill |
Geometrically engineered particles and methods for modulating macrophage or immune responses
|
CN102516232A
(zh)
|
2011-12-14 |
2012-06-27 |
无锡美克赛医药科技有限公司 |
一种ErbB2的小分子选择性抑制剂及其应用
|
EP2790733B1
(en)
|
2011-12-14 |
2019-10-30 |
The Johns Hopkins University |
Nanoparticles with enhanced mucosal penetration or decreased inflammation
|
US10046121B2
(en)
|
2011-12-27 |
2018-08-14 |
Vectura Gmbh |
Inhalation device with feedback system
|
CN104936620B
(zh)
|
2012-01-19 |
2019-08-09 |
约翰霍普金斯大学 |
增强粘膜渗透的纳米粒子调配物
|
WO2013116061A1
(en)
|
2012-02-03 |
2013-08-08 |
Forsight Vision4, Inc. |
Insertion and removal methods and apparatus for therapeutic devices
|
PL2846859T3
(pl)
|
2012-03-09 |
2017-07-31 |
Vectura Gmbh |
Kanał mieszania do urządzenia do inhalacji i urządzenie do inhalacji
|
CA2867381C
(en)
|
2012-03-16 |
2016-09-20 |
The Johns Hopkins University |
Controlled release formulations for the delivery of hif-1 inhibitors
|
CN104394891B
(zh)
|
2012-03-16 |
2019-04-16 |
约翰霍普金斯大学 |
用于递送活性剂的非线性多嵌段共聚物-药物结合物
|
US20140107025A1
(en)
|
2012-04-16 |
2014-04-17 |
Jade Therapeutics, Llc |
Ocular drug delivery system
|
US9827191B2
(en)
|
2012-05-03 |
2017-11-28 |
The Johns Hopkins University |
Compositions and methods for ophthalmic and/or other applications
|
CA2871778C
(en)
|
2012-05-03 |
2022-09-13 |
Kala Pharmaceuticals, Inc. |
Pharmaceutical nanoparticles showing improved mucosal transport
|
KR102154880B1
(ko)
|
2012-05-03 |
2020-09-10 |
칼라 파마슈티컬스, 인크. |
개선된 점막 수송을 나타내는 제약 나노입자
|
SG11201406973PA
(en)
*
|
2012-05-04 |
2014-12-30 |
Novartis Ag |
Complement pathway modulators and uses thereof
|
EP2849728A1
(en)
|
2012-05-04 |
2015-03-25 |
The Johns Hopkins University |
Lipid-based drug carriers for rapid penetration through mucus linings
|
EA201590053A1
(ru)
|
2012-06-20 |
2015-08-31 |
Новартис Аг |
Модуляторы пути системы комплемента и их применение
|
JP6273274B2
(ja)
|
2012-06-28 |
2018-01-31 |
ノバルティス アーゲー |
補体経路モジュレーターおよびその使用
|
EP2867227B1
(en)
|
2012-06-28 |
2018-11-21 |
Novartis AG |
Complement pathway modulators and uses thereof
|
WO2014002052A1
(en)
|
2012-06-28 |
2014-01-03 |
Novartis Ag |
Pyrrolidine derivatives and their use as complement pathway modulators
|
JP6155332B2
(ja)
|
2012-06-28 |
2017-06-28 |
ノバルティス アーゲー |
ピロリジン誘導体、および補体経路調節因子としてのその使用
|
AU2013282768A1
(en)
|
2012-06-28 |
2015-01-22 |
Novartis Ag |
Pyrrolidine derivatives and their use as complement pathway modulators
|
CN104603126B
(zh)
|
2012-06-28 |
2017-05-31 |
诺华股份有限公司 |
吡咯烷衍生物及其作为补体途径调节剂的用途
|
WO2014005150A1
(en)
|
2012-06-29 |
2014-01-03 |
Novartis Ag |
Crystalline forms of l-(2-((lr,3s,5r)-3-( (2 -fluoro-3 - (trifluoromethoxy) phenyl) carbamoyl) - 2 -azabicycl o [3.1.0] hexan- 2 -yl) - 2 -oxoethyl) - 5 -methyl - 1h - pyrazolo [3, 4 -c] pyridine - 3 - carboxami de and salts thereof
|
WO2014002059A1
(en)
|
2012-06-29 |
2014-01-03 |
Novartis Ag |
CRYSTALLINE FORMS OF 1-(2-((1R,3S,5R)-3-(((R)-1-(3-chloro-2-fluorophenyl)ethyl)carbamoyl)-2-azabicyclo[3.1.0]hexan-2-yl)-2-oxoethyl)-1Hpyrazolo[3,4-c]pyridine-3-carboxamide
|
JP6238980B2
(ja)
|
2012-07-12 |
2017-11-29 |
ノバルティス アーゲー |
補体経路モジュレーターおよびその使用
|
ES1077714Y
(es)
|
2012-07-31 |
2012-12-20 |
Gutierrez Jose Ramon Perez |
Envase de madera
|
WO2014035876A1
(en)
|
2012-08-27 |
2014-03-06 |
William Marsh Rice University |
Heat-inactivated complement factor b compositions and methods
|
CN104822370A
(zh)
|
2012-09-17 |
2015-08-05 |
佰恩德治疗股份有限公司 |
包含治疗剂的治疗性纳米颗粒及其制备和使用方法
|
US20150265541A1
(en)
|
2012-09-20 |
2015-09-24 |
Akina, Inc. |
Biodegradable Microcapsules Containing Filling Material
|
US9750636B2
(en)
|
2012-10-26 |
2017-09-05 |
Forsight Vision5, Inc. |
Ophthalmic system for sustained release of drug to eye
|
PL2724741T3
(pl)
|
2012-10-26 |
2017-11-30 |
Vectura Gmbh |
Urządzenie inhalacyjne do stosowania w terapii aerozolowej
|
AU2014236455B2
(en)
|
2013-03-14 |
2018-07-12 |
Forsight Vision4, Inc. |
Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
|
EP2970269B1
(en)
*
|
2013-03-14 |
2017-04-19 |
Novartis AG |
2-(1h-indol-4-ylmethyl)-3h-imidazo[4,5-b]pyridine-6-carbonitrile derivatives as complement factor b inhibitors useful for the treatment of ophthalmic diseases
|
JP6385423B2
(ja)
|
2013-03-28 |
2018-09-05 |
フォーサイト・ビジョン フォー・インコーポレーテッド |
治療物質送達用の眼移植片
|
WO2014165308A2
(en)
|
2013-04-01 |
2014-10-09 |
Allergan, Inc. |
Microsphere drug delivery system for sustained intraocular release
|
JO3425B1
(ar)
|
2013-07-15 |
2019-10-20 |
Novartis Ag |
مشتقات البابيريدينيل-اندول واستخدامها كعامل متمم لمثبطات b
|
WO2015009977A1
(en)
|
2013-07-18 |
2015-01-22 |
Novartis Ag |
Aminomethyl-biaryl derivatives as complement factor d inhibitors and uses thereof
|
RU2662967C2
(ru)
|
2013-09-13 |
2018-07-31 |
Ионис Фармасьютикалз, Инк. |
Модуляторы фактора в комплемента
|
EP3057514A4
(en)
|
2013-10-15 |
2017-08-02 |
Forsight Vision5, Inc. |
Formulations and methods for increasing or reducing mucus
|
WO2015066241A1
(en)
|
2013-10-30 |
2015-05-07 |
Novartis Ag |
2-benzyl-benzimidazole complement factor b inhibitors and uses thereof
|
WO2015085234A1
(en)
|
2013-12-06 |
2015-06-11 |
Forsight Vision4, Inc. |
Implantable therapeutic devices
|
US20160296627A1
(en)
|
2013-12-06 |
2016-10-13 |
Envisia Therapeutics Inc. |
Intracameral implant for treatment of an ocular condition
|
CN109414441A
(zh)
*
|
2016-06-27 |
2019-03-01 |
艾其林医药公司 |
治疗医学障碍的喹唑啉和吲哚化合物
|